[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@MedUpdateOn1ine Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1194670770082996226.png) @MedUpdateOn1ine MedicalUpdateOnline

MedicalUpdateOnline posts on X about novartis, longterm, as one, medtronic the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1194670770082996226/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1194670770082996226/c:line/m:interactions.svg)

- X Week XXX +0.49%
- X Month XXXXX +18%
- X Months XXXXX +43%
- X Year XXXXXX -XXX%

### Mentions: X [#](/creator/twitter::1194670770082996226/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1194670770082996226/c:line/m:posts_active.svg)

- X Week XX +17%
- X Month XX -XXXX%
- X Months XXX +53%
- X Year XXX +35%

### Followers: XXXXX [#](/creator/twitter::1194670770082996226/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1194670770082996226/c:line/m:followers.svg)

- X Week XXXXX +0.11%
- X Month XXXXX +0.42%
- X Months XXXXX +3.20%
- X Year XXXXX +4.20%

### CreatorRank: undefined [#](/creator/twitter::1194670770082996226/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1194670770082996226/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1194670770082996226/influence)
---

**Social category influence**
[stocks](/list/stocks) 

**Social topic influence**
[novartis](/topic/novartis), [longterm](/topic/longterm), [as one](/topic/as-one), [medtronic](/topic/medtronic), [people with](/topic/people-with), [$abbv](/topic/$abbv), [spotlight](/topic/spotlight), [gilead sciences](/topic/gilead-sciences), [eli lilly](/topic/eli-lilly)

**Top assets mentioned**
[Novartis AG (NVS)](/topic/novartis) [Medtronic PLC (MDT)](/topic/medtronic) [AbbVie Inc (ABBV)](/topic/$abbv) [Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences) [Eli Lilly and Company (LLY)](/topic/eli-lilly)
### Top Social Posts [#](/creator/twitter::1194670770082996226/posts)
---
Top posts by engagements in the last XX hours

"Alexion to present long-term Ultomiris and Soliris data in NMOSD at ECTRIMS 2025"  
[X Link](https://x.com/MedUpdateOn1ine/status/1969235124463001830) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-09-20T03:00Z 6222 followers, XX engagements


"New three-year data demonstrates sustained clinical benefits and established safety profile of Ingrezza (valbenazine) capsules for Huntington's disease chorea - Neurocrine Biosciences"  
[X Link](https://x.com/MedUpdateOn1ine/status/1976452689853620404) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-10T01:00Z 6225 followers, XXX engagements


"Evkeeza (evinacumab-dgnb) ANGPTL3 antibody approved by FDA for children as young as one year old with homozygous hypercholesterolemia - Regeneron"  
[X Link](https://x.com/MedUpdateOn1ine/status/1977177447968686483) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-12T01:00Z 6226 followers, XX engagements


"Groundbreaking study published in JAMA Neurology demonstrates effectiveness of BrainSense Adaptive deep brain stimulation for people with Parkinsons - Medtronic"  
[X Link](https://x.com/MedUpdateOn1ine/status/1977902248635040157) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-14T01:00Z 6226 followers, XX engagements


"United Therapeutics will present new findings on pulmonary hypertension and inhaled treprostinil at CHEST 2025"  
[X Link](https://x.com/MedUpdateOn1ine/status/1979019606950813980) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-17T03:00Z 6225 followers, XX engagements


"FDA approves updated indication statement for Rinvoq (upadacitinib) for the treatment of inflammatory bowel disease - AbbVie"  
[X Link](https://x.com/MedUpdateOn1ine/status/1980076562482409495) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-20T01:00Z 6226 followers, XX engagements


"Find out how key opinion leaders have developed innovative clinical services and new technologies in our video series 'In The Spotlight'"  
[X Link](https://x.com/MedUpdateOn1ine/status/1980710743751197054) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-21T19:00Z 6226 followers, XX engagements


"Fabhalta (iptacopan) meets Phase III primary endpoint slows kidney function decline in patients with IgA nephropathy - Novartis"  
[X Link](https://x.com/MedUpdateOn1ine/status/1980801339060854910) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-22T01:00Z 6225 followers, XX engagements


"Gilead Sciences to present new antiviral research across HIV hepatitis and respiratory viruses at IDWeek 2025"  
[X Link](https://x.com/MedUpdateOn1ine/status/1980215913560277000) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-20T10:13Z 6225 followers, XXX engagements


"PSMAddition data show Pluvicto delays progression to end-stage prostate cancer - Novartis"  
[X Link](https://x.com/MedUpdateOn1ine/status/1981163724334375321) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-23T01:00Z 6223 followers, XX engagements


"Verzenio (abemaciclib) prolonged survival in HR+ HER2- high-risk early breast cancer with two years of treatment - Eli Lilly"  
[X Link](https://x.com/MedUpdateOn1ine/status/1981888494738747846) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-25T01:00Z 6222 followers, XX engagements